Related Experiment Video

Updated: Apr 17, 2026

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9
08:14

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9

Published on: August 28, 2018

8.7K

[Lipid control in high-risk patients: focus on PCSK9 inhibitors]

Pasquale Perrone Filardi, Stefania Paolillo, Bruno Trimarco

    Giornale Italiano Di Cardiologia (2006)
    |February 18, 2015
    PubMed

    Insights

    New therapies targeting PCSK9 effectively lower LDL-cholesterol for high-risk patients when statins are insufficient. These treatments offer a promising approach to cardiovascular risk reduction and achieving lipid targets.

    Area of Science:

    • Cardiovascular Medicine
    • Pharmacology
    • Biochemistry

    Background:

    • Elevated low-density lipoprotein (LDL)-cholesterol is a primary risk factor for cardiovascular events.
    • Statins effectively reduce LDL-cholesterol but face challenges with patient adherence and achieving target levels in high-risk individuals.
    • A significant unmet need exists for alternative lipid-lowering therapies in secondary prevention.

    Purpose of the Study:

    • To explore novel therapeutic strategies for managing hypercholesterolemia in high-risk patients.
    • To investigate the role of Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9) inhibition as a treatment for hypercholesterolemia.
    • To evaluate the efficacy and tolerability of PCSK9 inhibitors in achieving lipid targets.

    Main Methods:

    • Investigated the mechanism of PCSK9 in regulating LDL receptor expression and recycling.
    • Reviewed clinical data on monoclonal antibodies targeting PCSK9, specifically alirocumab and evolocumab.
    • Assessed the impact of PCSK9 inhibition on LDL-cholesterol levels, with and without concurrent statin therapy.

    Main Results:

    • PCSK9 inhibition significantly reduces LDL-cholesterol levels.
    • Monoclonal antibodies against PCSK9 demonstrate substantial LDL-cholesterol lowering efficacy.
    • These agents show good tolerability, offering an alternative or adjunct to statin therapy.

    Conclusions:

    • PCSK9 inhibition represents a promising therapeutic avenue for hypercholesterolemia management.
    • Alirocumab and evolocumab are effective in reducing LDL-cholesterol in high-risk patients.
    • Further trials will elucidate the full potential of PCSK9 inhibitors in primary and secondary cardiovascular prevention.

    More Related Videos

    LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

    LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

    Published on: November 17, 2018

    14.3K
    Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes10:33

    Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

    Published on: July 23, 2016

    11.4K

    Related Concept Videos

    Coronary Artery Disease IV: Preventive Measures01:26

    Coronary Artery Disease IV: Preventive Measures

    Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
    879
    Atherosclerosis III: Management01:26

    Atherosclerosis III: Management

    Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
    613
    Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

    Lipid-Lowering Drugs: Statins and Miscellaneous Agents

    Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
    1.9K
    Cholesterol: Significance and Regulation01:29

    Cholesterol: Significance and Regulation

    Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
    Considering cholesterol and...
    2.0K
    Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

    Blood Studies for Cardiovascular System III: Serum Lipid Profile

    Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
    Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
    Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
    877
    Lipids: Dietary Sources and Requirements01:18

    Lipids: Dietary Sources and Requirements

    Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
    2.8K